Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Véronique Winnepenninckx(Morpho (United States)), Alan Spatz(Jewish General Hospital), Alain Sarasin(Institut Gustave Roussy), Vladimir Lazar(Institut Gustave Roussy), Thomas Robert(Aix-Marseille Université), Ovidiu Bălăcescu(Institute of Oncology Prof. Dr. Ion Chiricuta), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Thomas Tursz(Institut Gustave Roussy), Alexander M.M. Eggermont(University Medical Center Utrecht), Stefan Michiels(Institut Gustave Roussy), Philippe Dessen(Centre National de la Recherche Scientifique), Joost J. van den Oord(KU Leuven), Marie‐Françoise Avril(Délégation Paris 7), Marguerite Stas(Morpho (United States)), Gilbert Lenoir, Soledad Alonso(Morpho (United States))
Cited by 480
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k